John Hardy: updates in neurodegeneration

Written by Lauren Pulling, Editor

In October 2017 we had the pleasure of attending ‘Clearing the brain: protein clearance in neurodegenerative disease’, a 1-day symposium organized by the Leonard Wolfson Experimental Neurology Centre (LWENC) at University College London (UCL; London, UK). The event saw researchers and clinicians from across the world come together to share the latest research and debate the future of the field, with topics spanning perivascular clearance, fluid biomarkers, glymphatics, lymphatics, and a lively panel discussion.
In this video, recorded at the event, we speak to John Hardy, Professor of Neuroscience at UCL. John tells us more about the symposium and gives his views on the latest updates in neurodegeneration, including what recent results in the aducanumab and solanezumab trials could mean for the search for Alzheimer’s treatments.

Want to find out more about the event? Catch up on our highlights in our Twitter Moment, plus have a look at our interviews with other speakers from the event:

You can also find out more about the LWENC, dementia research at UCL and the event itself via the links below:




  1. Neuro Central